"Completing the infrastructure workstream is a major de-risking milestone for Orom-Cross. Having hydro-grid power, water, ...

Alien Metals said its joint venture partner, West Coast Silver Ltd, has reported further "outstanding" assay results from the maiden diamond drilling programme at the Elizabeth Hill project. West ...

The Eastbourne, England-based manufacturer and distributor of steel tape and thixotropic gels under the Unitape and Unigel brands said pretax profit jumped 59% to GBP2.0 million in the first half of ...

Animalcare Group PLC on Friday said it has acquired a programme researching osteoarthritis treatment in horses and dogs. The York, England-based veterinary services and pharmaceuticals firm said it ...

(Alliance News) - Resolute Mining Ltd on Friday said it had a "very positive" first half of the year, amid a much higher realised gold price. The Africa-focused gold miner for the first half of 2025 ...

(Sharecast News) - London stocks were set for a steady open on Friday after closing at a fresh record a day earlier for the third day in a row, above 9,300. The FTSE 100 was called to open flat at ...

Chair Iain McDonald commented: "Revolution Beauty is a great brand, but the business has lost its way. We are confident that with a return to the founder-led management team who originally scaled the ...

While London South East do their best to maintain the high quality of the information displayed on this site, we cannot ...

(Sharecast News) - London stocks edged lower in early trade on Friday after closing at a fresh record a day earlier for the third session in a row, as investors eyed an upcoming speech by Federal ...

(Sharecast News) - London stocks ended mixed on Thursday as traders digested a surprise increase in US initial jobless claims, a series of domestic data releases, and looked ahead to the Federal ...

As a result, yard services offered at the Fordoun site, including storage and inspection, will end upon the completion of existing contracts. Hunting expects this further restructuring to deliver ...

Helping its loss narrow was a 77% advance in revenue to USD21.4 million from USD12.1 million, with Shield Therapeutics benefitting from increased US sales of Accrufer. Sales in the region climbed 75% ...